Investing.com - Mylan reported third quarter earnings that beat analysts' expectations on Tuesday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.17 on revenue of $2.96B. Analysts polled by Investing.com forecast EPS of $1.13 on revenue of $3.01B. That compared to EPS of $1.25 on revenue of $2.83B in the same period a year earlier. The company had reported EPS of $1.03 on revenue of $2.85B in the previous quarter.
Mylan follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Merck&Co earnings beat analysts' expectations on October 29, with third quarter EPS of $1.51 on revenue of $12.4B. Investing.com analysts expected EPS of $1.24 on revenue of $11.64B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar